Lamotrigine (common brands : Lamictal DC, Lamitor) is a phenyltriazine
anticonvulsant, anti-seizure medication. Lamotrigine is used alone or in
combination with other drugs to treat partial epileptic seizures in adults.
See Warning for children under age 16. In addition to treating epilepsy,
Lamotrigine is often used for other unlicensed (off label) ADULT psychiatric uses:
As a mood stabilizer for treating the psychiatric illnesses, bipolar affective disorder and for the
treatment of post-traumatic stress disorder (PTSD) and/or borderline personality disorder (BPD).
Other off label uses of Lamotrigine: Treatment of trigeminal neuralgia, where the facial
nerves spontaneously send messages of pain to the brain. Lamotrigine prevents the nerve
signals being sent inappropriately and relieves the pain of this condition.
Ordering options for brand [Lamitor DC] and the generic [Lamotrigine] below.
No prescription is needed, but some pharmacies will require a consultation via questionnaire
to enable their staff physician to issue a prescription (this is a free consultation).
Other pharmacies do not require a consultation (no consultation needed)*
Lamotrigine drug interactions
Depakote/Depakene (valproic acid). Valproic acid levels decrease when Lamotrigine is added,
Therefore Lamotrigine levels increase (up to 2 to 3 times) on the same dose of Lamotrigine.
Tegretol (Carbamazepine), Phenobarbital and Dilantin (Phenytoin) and
Mysoline (Primidone), decrease Lamotrigine levels. Other drugs can affect, or be affected by Lamotrigine.
Lamotrigine Side Effects
The most common side effects caused by Lamotrigine are: dizziness, headache, blurred or
double vision, lack of coordination, sleepiness, nausea, vomiting and skin rash.
In a small number of people, Lamotrigine causes a serious skin rash requiring hospital
New warnings and revised labeling issued by Glaxo Wellcome (manufacturers of Lamictal)
Due to reports of severe, potentially life-threatening rash, including Stevens-Johnson syndrome
and rarely, toxic epidermal necrolysis, being higher when Lamictal is used by pediatric patients,
the revised labeling now includes a boxed warning which emphasizes that Lamictal is not
indicated for use in patients below the age of 16 years. Read Full Lamictal Warning Here